THE USE OF XO INHIBITORS IN CKD - PROS AND CONS

Dalbeth, Nicola

dc.contributor.author	Dalbeth, Nicola	en
dc.coverage.spatial	Amsterdam, NETHERLANDS	en
dc.date.accessioned	2019-05-28T01:43:55Z	en
dc.date.issued	2018-06-01	en
dc.identifier.issn	0003-4967	en
dc.identifier.uri	http://hdl.handle.net/2292/46637	en
dc.publisher	BMJ PUBLISHING GROUP	en
dc.relation.ispartof	Congress of the European-League-Against-Rheumatism (EULAR)	en
dc.relation.ispartofseries	ANNALS OF THE RHEUMATIC DISEASES	en
dc.rights	Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.	en
dc.rights.uri	https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm	en
dc.subject	Science & Technology	en
dc.subject	Life Sciences & Biomedicine	en
dc.subject	Rheumatology	en
dc.title	THE USE OF XO INHIBITORS IN CKD - PROS AND CONS	en
dc.type	Conference Item	en
dc.identifier.doi	10.1136/annrheumdis-2018-eular.7766	en
pubs.begin-page	44	en
pubs.volume	77	en
dc.rights.holder	Copyright: The author	en
pubs.author-url	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000444351000166&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=6e41486220adb198d0efde5a3b153e7d	en
pubs.end-page	44	en
pubs.finish-date	2018-06-16	en
pubs.publication-status	Published	en
pubs.start-date	2018-06-13	en
dc.rights.accessrights	http://purl.org/eprint/accessRights/RestrictedAccess	en
pubs.elements-id	755098	en
pubs.org-id	Medical and Health Sciences	en
pubs.org-id	School of Medicine	en
pubs.org-id	Medicine Department	en
dc.identifier.eissn	1468-2060	en